180 Life Sciences Corp ATNF:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/04/21 EST
3.94quote price arrow down-0.49 (-11.06%)
Volume
846,759
52 week range
1.90 - 11.50

...

Loading . . .

KEY STATS

  • Open4.40
  • Day High4.55
  • Day Low3.71
  • Prev Close3.94
  • 52 Week High11.50
  • 52 Week High Date06/17/20
  • 52 Week Low1.90
  • 52 Week Low Date11/19/20
  • Market Cap94.99M
  • Shares Out24.11M
  • 10 Day Average Volume1.34M
  • Dividend-
  • Dividend Yield-
  • Beta-0.89
  • 1 Year % Change-62.9

RATIOS/PROFITABILITY

  • EPS (TTM)-1.97
  • P/E (TTM)-2.00
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-5.969M
  • ROE (MRQ)-37.54%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)55.15%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest 180 Life Sciences Corp News

There is no recent news for this security.

Latest ATNF News From Our Partners

QUOTE FINDER

Profile

MORE
180 Life Sciences Corp., (180 Life Sciences) formerly KBL Merger Corp. IV., is a research and development company. The Company is focused on research into solving one of the diseases is inflammation. The Company consists of three programs developing drugs in separate areas of inflammation. The Company’s pipeline, including Fibrosis and Anti-TNF, SCAs and a7nAChR. The Fibrosis and Anti-TNF treats diseases like Dupuytren’s contracture, frozen shoulder, polycystic ovarian...
James Woody
Chief Executive Officer
Ozan Pamir
Chief Financial Officer
Address
150 WEST 56TH STREET SUITE 5901
New York, NY
10019
United States